JPH0413997B2 - - Google Patents
Info
- Publication number
- JPH0413997B2 JPH0413997B2 JP5390187A JP5390187A JPH0413997B2 JP H0413997 B2 JPH0413997 B2 JP H0413997B2 JP 5390187 A JP5390187 A JP 5390187A JP 5390187 A JP5390187 A JP 5390187A JP H0413997 B2 JPH0413997 B2 JP H0413997B2
- Authority
- JP
- Japan
- Prior art keywords
- virus
- infectious bronchitis
- collection
- culture
- national
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000711450 Infectious bronchitis virus Species 0.000 claims description 19
- 244000144977 poultry Species 0.000 claims description 11
- 238000006386 neutralization reaction Methods 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 4
- 241000700605 Viruses Species 0.000 description 44
- 229960005486 vaccine Drugs 0.000 description 26
- 238000012360 testing method Methods 0.000 description 19
- 241000287828 Gallus gallus Species 0.000 description 13
- 235000013330 chicken meat Nutrition 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 9
- 235000013594 poultry meat Nutrition 0.000 description 9
- 241000271566 Aves Species 0.000 description 8
- 206010006451 bronchitis Diseases 0.000 description 8
- 230000002458 infectious effect Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000010530 Virus Neutralization Effects 0.000 description 4
- 230000002238 attenuated effect Effects 0.000 description 4
- 230000002163 immunogen Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 244000144992 flock Species 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 230000017448 oviposition Effects 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010029803 Nosocomial infection Diseases 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000172104 Connecticut virus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000027645 antigenic variation Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7908687 | 1979-11-30 | ||
NL7908687A NL7908687A (nl) | 1979-11-30 | 1979-11-30 | Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins. |
NL8005083 | 1980-09-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62275680A JPS62275680A (ja) | 1987-11-30 |
JPH0413997B2 true JPH0413997B2 (hu) | 1992-03-11 |
Family
ID=19834260
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16945680A Granted JPS5692823A (en) | 1979-11-30 | 1980-12-01 | Infectious bronchitis vaccine for poultry and its manufacture |
JP62053901A Granted JPS62275680A (ja) | 1979-11-30 | 1987-03-09 | 家禽の伝染性気管支炎ウイルス株 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16945680A Granted JPS5692823A (en) | 1979-11-30 | 1980-12-01 | Infectious bronchitis vaccine for poultry and its manufacture |
Country Status (3)
Country | Link |
---|---|
JP (2) | JPS5692823A (hu) |
NL (1) | NL7908687A (hu) |
ZA (1) | ZA807459B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE31830E (en) * | 1979-11-13 | 1985-02-12 | Gist-Brocades N.V. | Infectious bronchitis vaccine for poultry |
US4357320A (en) * | 1980-11-24 | 1982-11-02 | Gist-Brocades N. V. | Infectious bronchitis vaccine for poultry |
EP0073856A1 (en) * | 1981-08-28 | 1983-03-16 | Gist-Brocades N.V. | Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain |
JPH02188218A (ja) * | 1989-01-18 | 1990-07-24 | Matsushita Electric Ind Co Ltd | ピンポイントゲート開閉金型装置 |
-
1979
- 1979-11-30 NL NL7908687A patent/NL7908687A/nl not_active Application Discontinuation
-
1980
- 1980-11-28 ZA ZA00807459A patent/ZA807459B/xx unknown
- 1980-12-01 JP JP16945680A patent/JPS5692823A/ja active Granted
-
1987
- 1987-03-09 JP JP62053901A patent/JPS62275680A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5692823A (en) | 1981-07-27 |
NL7908687A (nl) | 1981-07-01 |
JPS6244528B2 (hu) | 1987-09-21 |
JPS62275680A (ja) | 1987-11-30 |
ZA807459B (en) | 1981-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cook | The classification of new serotypes of infectious bronchitis virus isolated from poultry flocks in Britain between 1981 and 1983 | |
CA1204055A (en) | Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain | |
US6086892A (en) | Poultry vaccine | |
Winterfield et al. | Immunological characteristics of a variant of infectious bronchitis virus isolated from chickens | |
Pensaert et al. | Vaccination of chickens against a Belgian nephropathogenic strain of infectious bronchitis virus B1648 using attenuated homologous and heterologous strains | |
Otsuki et al. | Preparation and immunological response to a new mixed vaccine composed of inactivated Newcastle disease virus, inactivated infectious bronchitis virus, and inactivated Hemophilus gallinarum | |
Barbour et al. | Infection and immunity in broiler chicken breeders vaccinated with a temperature-sensitive mutant of Mycoplasma gallisepticum and impact on performance of offspring | |
Andrade et al. | Vaccination of day-old broilers against infectious bronchitis: effect of vaccine strain and route of administration | |
GB1593567A (en) | Live newcastle disease virus vaccine | |
EP0030063B1 (en) | Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strains | |
JPH05260962A (ja) | ニワトリ貧血因子ワクチン | |
Gelb Jr et al. | Effect of serial embryo passage of an Arkansas-type avian infectious bronchitis virus isolate on clinical response, virus recovery, and immunity | |
HU189222B (en) | Process for preparing a new vaccine against infectious bronchytis | |
KR100531491B1 (ko) | 백신으로서 소 호흡 코로나바이러스 | |
Smithies et al. | Two different type A influenza virus infections in turkeys in Wisconsin II. 1968 outbreak | |
JPH0413997B2 (hu) | ||
Nerome et al. | Isolation and serological characterization of influenza A viruses from birds that were dead on arrival at Tokyo airport | |
Marquardt et al. | Comparison of ciliary activity and virus recovery from tracheas of chickens and humoral immunity after inoculation with serotypes of avian infectious bronchitis virus | |
Jackwood | Infectious bursal disease in poultry | |
Saif-Edin et al. | Epidemiological studies on Gumboro disease in upper Egypt | |
TAKASE et al. | Serological monitoring on layer farms with specific pathogen-free chickens | |
Winterfield et al. | Vaccination and revaccination with a Holland (H) strain of infectious bronchitis virus | |
Chettle et al. | Failure of maternally derived infectious bursal disease antibodies to serotypes 1 and 2 to protect against heterologous virus | |
Pahar et al. | The characterization of infectious bursal disease virus strains/isolates from field outbreaks in India | |
Yachida et al. | Effectiveness of maternal antibody against challenge with infectious bronchitis viruses |